BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 214 filers reported holding BLUEPRINT MEDICINES CORP in Q1 2023. The put-call ratio across all filers is 2.33 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,956,725 | +9.6% | 98,680 | +38.1% | 0.01% | +11.1% |
| Q2 2023 | $4,521,332 | +11.0% | 71,480 | -21.0% | 0.01% | +12.5% |
| Q1 2023 | $4,072,763 | +49.5% | 90,526 | +45.6% | 0.01% | +33.3% |
| Q4 2022 | $2,724,368 | -40.7% | 62,186 | -10.8% | 0.01% | -40.0% |
| Q3 2022 | $4,593,000 | +37.4% | 69,726 | +5.3% | 0.01% | +42.9% |
| Q2 2022 | $3,343,000 | +57.2% | 66,216 | +98.9% | 0.01% | +75.0% |
| Q1 2022 | $2,126,000 | -55.3% | 33,299 | -25.0% | 0.00% | -50.0% |
| Q4 2021 | $4,756,000 | -16.0% | 44,424 | -19.4% | 0.01% | -20.0% |
| Q3 2021 | $5,662,000 | +7.2% | 55,088 | -8.4% | 0.01% | +11.1% |
| Q2 2021 | $5,284,000 | +63.2% | 60,114 | +80.4% | 0.01% | +50.0% |
| Q1 2021 | $3,238,000 | -20.0% | 33,314 | -7.6% | 0.01% | -25.0% |
| Q4 2020 | $4,048,000 | +10.2% | 36,065 | -9.1% | 0.01% | 0.0% |
| Q3 2020 | $3,674,000 | +29.7% | 39,665 | +9.2% | 0.01% | +33.3% |
| Q2 2020 | $2,832,000 | +10.0% | 36,336 | -17.6% | 0.01% | -14.3% |
| Q1 2020 | $2,575,000 | -27.0% | 44,073 | +0.1% | 0.01% | 0.0% |
| Q4 2019 | $3,527,000 | +64.1% | 44,030 | +50.5% | 0.01% | +75.0% |
| Q3 2019 | $2,149,000 | +16.4% | 29,253 | +49.3% | 0.00% | +33.3% |
| Q2 2019 | $1,847,000 | -0.3% | 19,592 | -15.5% | 0.00% | 0.0% |
| Q1 2019 | $1,852,000 | +48.5% | 23,182 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $1,247,000 | -39.1% | 23,182 | -11.7% | 0.00% | -25.0% |
| Q3 2018 | $2,049,000 | +55.8% | 26,253 | +26.6% | 0.00% | +33.3% |
| Q2 2018 | $1,315,000 | -41.4% | 20,733 | -15.3% | 0.00% | -25.0% |
| Q1 2018 | $2,244,000 | +68.0% | 24,474 | +41.6% | 0.00% | +100.0% |
| Q4 2017 | $1,336,000 | -22.9% | 17,288 | -30.5% | 0.00% | -33.3% |
| Q3 2017 | $1,733,000 | +2.2% | 24,886 | -25.6% | 0.00% | 0.0% |
| Q2 2017 | $1,695,000 | +301.7% | 33,452 | +216.7% | 0.00% | +200.0% |
| Q1 2017 | $422,000 | +38.4% | 10,562 | -3.7% | 0.00% | 0.0% |
| Q4 2016 | $305,000 | – | 10,964 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 379,090 | $19,037,900 | 17.25% |
| DAFNA Capital Management LLC | 249,521 | $12,530,945 | 3.90% |
| Rock Springs Capital Management LP | 2,685,294 | $134,855,465 | 3.61% |
| Casdin Capital, LLC | 371,378 | $18,650,603 | 2.06% |
| Novo Holdings A/S | 525,000 | $26,365,500 | 1.95% |
| CHI Advisors LLC | 92,888 | $4,664,835 | 1.85% |
| SECTORAL ASSET MANAGEMENT INC | 165,890 | $8,330,996 | 1.62% |
| Avidity Partners Management LP | 751,600 | $37,745,352 | 1.52% |
| EMERALD ADVISERS, LLC | 607,037 | $30,485,393 | 1.48% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 464,321 | $23,318,201 | 1.41% |